Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.32 trillion and total revenue of $123.28 billion.
Market Cap
1.32T
Revenue
123.28B
Profits
-33.02B
PE Ratio
n/a
Profit Margin
-26.78%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.56B | -0.74% | 487,091 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 95.88B | 0.45% | 1,165,614 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 90.38B | -3.45% | 6,945,237 | 2.53B |
| 4 | ARGX | argenx SE | 59.30B | -2.17% | 225,890 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 47.58B | 0.14% | 345,436 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.76B | 0.84% | 2,951,369 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 37.27B | -2.30% | 2,654,234 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.22B | -0.72% | 3,733,328 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.64B | -1.15% | 6,031,949 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.58B | 2.62% | 1,543,587 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.66B | -0.60% | 950,495 | 6.01B |
| 12 | ALNY | Alnylam Pharmaceuticals, Inc. | 22.11B | 5.36% | 3,046,645 | 5.01B |
| 13 | BNTX | BioNTech SE | 21.22B | 0.66% | 844,753 | 2.75B |
| 14 | ASND | Ascendis Pharma A/S | 18.06B | 3.12% | 826,058 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.84B | -1.20% | 1,522,001 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.50B | 0.49% | 496,698 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.25B | 0.17% | 1,149,255 | 945.54M |
| 18 | TECH | Bio-Techne Corporation | 11.44B | 0.05% | 2,491,009 | 1.23B |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.43B | -0.40% | 1,943,605 | 1.80B |
| 20 | SMMT | Summit Therapeutics Inc. | 11.32B | -6.14% | 5,097,072 | - |
| 21 | MTRI | Mentari Therapeutics, Inc. | 11.18B | 1.36% | 11,913 | - |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.09B | 0.93% | 1,466,196 | 3.66B |
| 23 | KYMR | Kymera Therapeutics, Inc. | 10.89B | 0.31% | 808,713 | 102.24M |
| 24 | PCVX | Vaxcyte, Inc. | 10.03B | -2.04% | 623,598 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.93B | 0.51% | 441,233 | 1.43B |
| 26 | SYRE | Spyre Therapeutics, Inc. | 9.88B | 1.06% | 746,232 | - |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 9.17B | 1.04% | 352,864 | 7.46M |
| 28 | KRYS | Krystal Biotech, Inc. | 9.05B | -0.15% | 110,280 | 470.03M |
| 29 | TGTX | TG Therapeutics, Inc. | 9.04B | -0.08% | 1,095,871 | 897.76M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -2.55% | 759,906 | 551.69M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.98B | -1.04% | 1,112,931 | 963.65M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.97B | 4.70% | 1,158,733 | 280.75M |
| 33 | CYTK | Cytokinetics, Incorporated | 7.82B | -0.05% | 1,013,555 | 113.29M |
| 34 | AXSM | Axsome Therapeutics, Inc. | 7.45B | -1.86% | 973,045 | 865.27M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.39B | -2.90% | 698,950 | 5.33M |
| 36 | KOD | Kodiak Sciences Inc. | 7.26B | 2.72% | 972,129 | - |
| 37 | ORKA | Oruka Therapeutics, Inc. | 7.15B | 0.34% | 679,676 | - |
| 38 | IMVT | Immunovant, Inc. | 7.07B | -2.48% | 864,838 | - |
| 39 | TWST | Twist Bioscience Corporation | 7.00B | -2.29% | 2,046,248 | 459.43M |
| 40 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.75B | 1.34% | 3,113,428 | 450.82M |
| 41 | CGON | CG Oncology, Inc. | 6.65B | 6.06% | 3,238,514 | 6.17M |
| 42 | BLTE | Belite Bio, Inc | 6.62B | -3.30% | 216,974 | - |
| 43 | CAI | Caris Life Sciences, Inc. | 6.61B | -3.84% | 3,021,304 | 1.05B |
| 44 | IBRX | ImmunityBio, Inc. | 6.40B | -0.82% | 12,568,917 | 182.57M |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.18B | -2.37% | 99,355 | 253.83M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.14B | 0.71% | 331,054 | 670.78M |
| 47 | ERAS | Erasca, Inc. | 5.50B | -0.76% | 8,533,403 | - |
| 48 | MANE | Veradermics, Incorporated | 5.47B | -4.16% | 938,026 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.30B | 0.21% | 502,867 | 1.16B |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.27B | 0.10% | 623,481 | 570.00K |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.17B | -0.72% | 681,518 | 2.72M |
| 52 | EWTX | Edgewise Therapeutics, Inc. | 5.03B | 0.24% | 1,162,441 | - |
| 53 | COGT | Cogent Biosciences, Inc. | 4.97B | -1.99% | 1,150,743 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 4.86B | -1.76% | 708,197 | 651.03M |
| 55 | IONS | Ionis Pharmaceuticals, Inc. | 4.84B | 6.41% | 5,948,628 | 960.09M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.39B | -2.79% | 778,178 | - |
| 57 | TNGX | Tango Therapeutics, Inc. | 4.32B | 2.62% | 2,677,674 | 53.81M |
| 58 | CRSP | CRISPR Therapeutics AG | 4.10B | -0.89% | 1,873,738 | 25.17M |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.00B | 0.06% | 1,478,162 | 10.35M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.98B | -1.26% | 607,633 | 7.50M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 3.96B | 4.41% | 732,091 | 682.20M |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.73B | 5.95% | 8,387,423 | - |
| 63 | ABCL | AbCellera Biologics Inc. | 3.72B | -1.12% | 2,409,689 | 67.85M |
| 64 | IRON | Disc Medicine, Inc. | 3.64B | -3.88% | 779,944 | - |
| 65 | ELVN | Enliven Therapeutics, Inc. | 3.59B | 1.01% | 972,559 | - |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 3.59B | 1.70% | 11,675,067 | 378.98M |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.57B | 2.65% | 858,150 | 508.68M |
| 68 | PBLS | Parabilis Medicines, Inc. | 3.56B | 2.67% | 555,139 | 2.26M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 3.51B | 1.28% | 1,204,162 | 26.31M |
| 70 | LEGN | Legend Biotech Corporation | 3.39B | -5.61% | 3,029,717 | 1.36B |
| 71 | ACAD | Acadia Pharmaceuticals Inc. | 3.24B | 3.36% | 1,785,340 | 1.20B |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.22B | 0.88% | 1,674,443 | - |
| 73 | CELC | Celcuity Inc. | 3.16B | 0.31% | 646,496 | - |
| 74 | TLX | Telix Pharmaceuticals Limited | 3.08B | -1.39% | 110,831 | 890.79M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 1.08% | 778,653 | 36.54M |
| 76 | ADMA | ADMA Biologics, Inc. | 3.03B | 3.32% | 4,160,093 | 519.15M |
| 77 | DNLI | Denali Therapeutics Inc. | 3.00B | -0.79% | 795,667 | 21.38M |
| 78 | VCEL | Vericel Corporation | 2.91B | -0.80% | 698,760 | 324.17M |
| 79 | XNCR | Xencor, Inc. | 2.78B | -2.73% | 958,131 | 200.49M |
| 80 | MBX | MBX Biosciences, Inc. | 2.78B | 2.62% | 855,453 | - |
| 81 | ZLAB | Zai Lab Limited | 2.77B | -5.53% | 1,224,326 | 441.73M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.51B | -1.91% | 1,138,756 | 100.00M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.42B | 0.85% | 1,674,201 | 25.94M |
| 84 | PHVS | Pharvaris N.V. | 2.34B | -1.39% | 182,571 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.28B | -4.99% | 2,045,050 | 146.64M |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.26B | 1.05% | 544,313 | 158.00K |
| 87 | PVLA | Palvella Therapeutics, Inc. | 2.23B | -0.46% | 241,726 | - |
| 88 | IMNM | Immunome, Inc. | 2.22B | 0.37% | 951,064 | 4.02M |
| 89 | LKFT | Lakefront Biotherapeutics NV | 2.14B | 0.15% | 287,836 | 1.13B |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -2.96% | 691,247 | 321.74M |
| 91 | BHVN | Biohaven Ltd. | 2.09B | -1.78% | 1,002,212 | - |
| 92 | REPL | Replimune Group, Inc. | 2.08B | -0.41% | 2,020,646 | - |
| 93 | VERA | Vera Therapeutics, Inc. | 2.03B | -3.24% | 1,013,532 | 10.28M |
| 94 | SEPN | Septerna, Inc. | 2.03B | 1.77% | 337,793 | 96.27M |
| 95 | RXRX | Recursion Pharmaceuticals, Inc. | 1.99B | -4.35% | 15,641,610 | 68.23M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | -0.12% | 844,885 | 989.36M |
| 97 | TRAX | First Tracks Biotherapeutics, Inc. | 1.98B | -3.29% | 461,930 | - |
| 98 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.96B | -1.82% | 1,992,204 | 213.00M |
| 99 | FTRE | Fortrea Holdings Inc. | 1.95B | 0.70% | 1,964,979 | 2.67B |
| 100 | TRVI | Trevi Therapeutics, Inc. | 1.95B | 0.22% | 1,099,900 | - |
| 101 | COAG | Hemab Therapeutics Holdings, Inc. | 1.91B | 3.76% | 401,087 | - |
| 102 | ZBIO | Zenas BioPharma, Inc. | 1.90B | 1.34% | 304,817 | 11.00M |
| 103 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | -0.54% | 371,332 | 140.84M |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.88B | -4.88% | 1,372,720 | 20.00M |
| 105 | ZYME | Zymeworks Inc. | 1.81B | -0.87% | 770,307 | 265.97M |
| 106 | LYCA | Lycia Therapeutics, Inc. | 1.80B | -4.96% | 189,539 | 4.44M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.83% | 420,232 | 28.21M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 0.37% | 1,324,990 | 1.96B |
| 109 | KLRA | Kailera Therapeutics, Inc. | 1.72B | 0.45% | 400,527 | - |
| 110 | MESO | Mesoblast Limited | 1.72B | 1.30% | 347,014 | 120.25M |
| 111 | VIR | Vir Biotechnology, Inc. | 1.71B | -17.82% | 15,782,558 | 302.80M |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.69B | -0.77% | 1,116,876 | 701.94M |
| 113 | QURE | uniQure N.V. | 1.67B | -3.33% | 1,394,445 | 20.17M |
| 114 | WWB | Windward Bio Group AG | 1.65B | 67.65% | 1,276,858 | - |
| 115 | RARE | Ultragenyx Pharmaceutical Inc. | 1.63B | -1.17% | 1,679,423 | 730.00M |
| 116 | PGEN | Precigen, Inc. | 1.63B | -2.58% | 3,777,110 | 156.94M |
| 117 | SLS | SELLAS Life Sciences Group, Inc. | 1.60B | -2.12% | 10,450,070 | - |
| 118 | BRVE | Braveheart Bio, Inc. | 1.60B | -4.29% | 536,604 | - |
| 119 | ADRX | ADARx Pharmaceuticals, Inc. | 1.59B | -4.76% | 587,958 | 6.13M |
| 120 | GENB | Generate Biomedicines, Inc. | 1.56B | -3.98% | 811,267 | 21.07M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.55B | 1.16% | 316,028 | 20.00M |
| 122 | IMCR | Immunocore Holdings plc | 1.55B | -1.76% | 270,294 | 429.30M |
| 123 | NBTX | Nanobiotix S.A. | 1.49B | -4.95% | 93,102 | 13.15M |
| 124 | ABSI | Absci Corporation | 1.46B | -7.50% | 5,485,311 | 1.49M |
| 125 | KRSA | Korsana Biosciences, Inc. | 1.44B | 1.18% | 225,508 | - |
| 126 | GPCR | Structure Therapeutics Inc. | 1.43B | 0.81% | 1,346,421 | - |
| 127 | NUVB | Nuvation Bio Inc. | 1.41B | -1.72% | 3,086,929 | 201.73M |
| 128 | NVAX | Novavax, Inc. | 1.41B | -2.68% | 4,250,928 | 411.65M |
| 129 | LBRX | LB Pharmaceuticals Inc | 1.39B | 1.30% | 330,168 | - |
| 130 | TYRA | Tyra Biosciences, Inc. | 1.38B | 1.32% | 375,086 | - |
| 131 | ANAB | AnaptysBio, Inc. | 1.38B | -3.18% | 499,637 | 60.04M |
| 132 | OCUL | Ocular Therapeutix, Inc. | 1.37B | -1.11% | 2,487,108 | 50.38M |
| 133 | NTLA | Intellia Therapeutics, Inc. | 1.36B | -8.06% | 8,821,338 | 52.89M |
| 134 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | -1.10% | 1,308,462 | - |
| 135 | INVA | Innoviva, Inc. | 1.35B | 0.32% | 560,886 | 438.32M |
| 136 | AVLN | Avalyn Pharma Inc. | 1.35B | -1.01% | 574,889 | - |
| 137 | DMRA | Damora Therapeutics, Inc. | 1.34B | -2.04% | 475,266 | - |
| 138 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | -2.61% | 2,474,554 | 5.49M |
| 139 | MNKD | MannKind Corporation | 1.33B | -0.72% | 1,686,713 | 413.37M |
| 140 | AAPG | Ascentage Pharma Group International | 1.32B | -2.66% | 8,735 | 94.61M |
| 141 | GHRS | GH Research PLC | 1.31B | 3.30% | 560,158 | - |
| 142 | KARD | Kardigan, Inc. | 1.29B | -2.12% | 410,885 | - |
| 143 | URGN | UroGen Pharma Ltd. | 1.28B | -0.80% | 700,012 | 250.25M |
| 144 | NKTR | Nektar Therapeutics | 1.27B | 0.05% | 695,165 | 52.19M |
| 145 | OMER | Omeros Corporation | 1.27B | -2.78% | 737,383 | 38.42M |
| 146 | SVRA | Savara Inc. | 1.25B | -1.69% | 3,231,765 | - |
| 147 | DRTS | Alpha Tau Medical Ltd. | 1.24B | 0.15% | 404,629 | - |
| 148 | SLN | Silence Therapeutics plc | 1.23B | 0.15% | 586,516 | 615.00K |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -5.07% | 245,896 | 2.00M |
| 150 | VOR | Vor Biopharma Inc. | 1.19B | 0.52% | 739,307 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.18B | -3.53% | 610,927 | - |
| 152 | SGP | SpyGlass Pharma, Inc. | 1.10B | -1.32% | 39,455 | - |
| 153 | SPTX | Seaport Therapeutics, Inc. | 1.07B | -0.75% | 346,855 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.06B | -2.87% | 1,190,709 | - |
| 155 | VSTM | Verastem, Inc. | 1.03B | -3.08% | 1,721,342 | 100.30M |
| 156 | JBIO | Jade Biosciences, Inc. | 1.03B | 1.70% | 593,498 | - |
| 157 | AKTS | Aktis Oncology, Inc. | 927.36M | 2.09% | 244,542 | 12.39M |
| 158 | ODTX | Odyssey Therapeutics, Inc. | 917.59M | -4.78% | 322,921 | 99.00K |
| 159 | CTY | City Therapeutics, Inc. | 900.60M | -4.64% | 482,372 | 14.34M |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 897.52M | 0.19% | 625,297 | - |
| 161 | MGTX | MeiraGTx Holdings plc | 897.17M | 4.44% | 732,221 | 401.91M |
| 162 | IMTX | Immatics N.V. | 873.45M | -1.99% | 586,386 | 49.33M |
| 163 | LTGO | Latigo Biotherapeutics, Inc. | 869.18M | 1.39% | 406,524 | - |
| 164 | PHAR | Pharming Group N.V. | 867.08M | -2.70% | 5,072 | 386.75M |
| 165 | SNDX | Syndax Pharmaceuticals, Inc. | 850.77M | -0.94% | 3,179,737 | 289.68M |
| 166 | IVA | Inventiva S.A. | 838.34M | -5.15% | 3,316,485 | 2.81M |
| 167 | RIGL | Rigel Pharmaceuticals, Inc. | 837.18M | -2.69% | 151,587 | 288.21M |
| 168 | BBTX | Bambusa Therapeutics, Inc. | 819.66M | -3.94% | 384,619 | - |
| 169 | ORIC | ORIC Pharmaceuticals, Inc. | 814.71M | -7.53% | 1,008,697 | - |
| 170 | GLUE | Monte Rosa Therapeutics, Inc. | 800.67M | 0.64% | 1,119,299 | 70.33M |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 796.97M | -1.65% | 1,893,364 | 38.54M |
| 172 | ARDX | Ardelyx, Inc. | 776.74M | -0.96% | 2,380,472 | 468.22M |
| 173 | OBX | Obsidian Therapeutics, Inc. | 775.87M | 0.64% | 314,041 | - |
| 174 | SLDB | Solid Biosciences Inc. | 763.42M | -2.29% | 975,452 | - |
| 175 | PRME | Prime Medicine, Inc. | 761.98M | 9.77% | 5,964,356 | 7.06M |
| 176 | ANNX | Annexon, Inc. | 747.79M | -1.26% | 2,585,706 | - |
| 177 | AURA | Aura Biosciences, Inc. | 739.97M | 0.00% | 610,303 | - |
| 178 | SGMT | Sagimet Biosciences Inc. | 729.38M | -6.50% | 759,442 | - |
| 179 | ALMS | Alumis Inc. | 727.00M | -8.65% | 1,492,368 | 7.24M |
| 180 | OABI | OmniAb, Inc. | 716.17M | -0.81% | 733,982 | 40.21M |
| 181 | KURA | Kura Oncology, Inc. | 713.90M | 4.58% | 2,227,255 | 79.31M |
| 182 | APMD | Apnimed, Inc. | 704.39M | 1.74% | 690,802 | 115.12M |
| 183 | NVCT | Nuvectis Pharma, Inc. | 696.03M | 0.05% | 208,982 | - |
| 184 | JANX | Janux Therapeutics, Inc. | 695.66M | -1.09% | 717,849 | 23.29M |
| 185 | ATTO | Attovia Therapeutics, Inc. | 690.70M | -4.30% | 322,873 | 1.44M |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 689.52M | 0.95% | 813,800 | 96.06M |
| 187 | ANL | Adlai Nortye Group Ltd. | 683.26M | 0.86% | 152,055 | 18.06M |
| 188 | AVBP | ArriVent BioPharma, Inc. | 672.92M | -0.46% | 616,142 | 5.00M |
| 189 | DSGN | Design Therapeutics, Inc. | 670.46M | -1.04% | 238,449 | - |
| 190 | CGEM | Cullinan Therapeutics, Inc. | 667.39M | 0.88% | 1,376,806 | - |
| 191 | BCAX | Bicara Therapeutics Inc. | 665.20M | -0.89% | 1,519,596 | - |
| 192 | OLMA | Olema Pharmaceuticals, Inc. | 662.30M | 0.53% | 1,696,511 | - |
| 193 | DBVT | DBV Technologies S.A. | 657.25M | -3.63% | 278,931 | 3.74M |
| 194 | IMMX | Immix Biopharma, Inc. | 657.09M | -2.85% | 1,027,812 | - |
| 195 | HELP | Helus Pharma Inc. | 648.04M | 0.11% | 979,145 | - |
| 196 | ABUS | Arbutus Biopharma Corporation | 626.97M | 1.49% | 3,311,219 | 181.49M |
| 197 | GERN | Geron Corporation | 622.98M | -2.72% | 4,410,547 | 217.52M |
| 198 | DNA | Ginkgo Bioworks Holdings, Inc. | 622.89M | -6.06% | 1,860,373 | 130.75M |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 621.76M | -2.00% | 1,146,661 | 6.40M |
| 200 | IAM | Iambic Therapeutics, Inc. | 620.95M | -11.73% | 277,980 | 18.25M |
| 201 | WVE | Wave Life Sciences, Inc. | 617.33M | -0.79% | 2,660,111 | 70.92M |
| 202 | CLYM | Climb Bio, Inc. | 608.53M | -4.69% | 667,804 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 605.64M | -1.53% | 284,754 | 15.00M |
| 204 | SANA | Sana Biotechnology, Inc. | 605.26M | 0.50% | 3,201,187 | - |
| 205 | SRZN | Surrozen, Inc. | 602.54M | -0.19% | 106,701 | 10.53M |
| 206 | OBIO | Orchestra BioMed Holdings, Inc. | 570.61M | 17.89% | 1,567,673 | 31.21M |
| 207 | ETRA | Electra Therapeutics, Inc. | 554.86M | -2.96% | 313,057 | - |
| 208 | CAPR | Capricor Therapeutics, Inc. | 554.09M | -6.93% | 3,509,877 | 11.13M |
| 209 | ENTX | Entera Bio Ltd. | 541.57M | -3.42% | 155,334 | 42.00K |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 540.30M | -18.64% | 2,941,991 | 147.76M |
| 211 | VALN | Valneva SE | 539.15M | -1.74% | 2,719 | 163.30M |
| 212 | EPRX | Eupraxia Pharmaceuticals Inc. | 535.93M | 4.35% | 777,239 | - |
| 213 | RGNX | REGENXBIO Inc. | 505.18M | -4.86% | 716,115 | 153.91M |
| 214 | NGNE | Neurogene Inc. | 495.37M | 0.13% | 193,615 | 925.00K |
| 215 | MNPR | Monopar Therapeutics Inc. | 487.93M | -0.94% | 189,546 | - |
| 216 | INDP | Indaptus Therapeutics, Inc. | 486.85M | 0.63% | 113,195 | - |
| 217 | CADL | Candel Therapeutics, Inc. | 486.36M | -26.10% | 6,622,128 | - |
| 218 | PHAT | Phathom Pharmaceuticals, Inc. | 481.35M | -2.73% | 1,509,710 | 274.88M |
| 219 | OVID | Ovid Therapeutics Inc. | 479.38M | -0.39% | 2,664,011 | 1.45M |
| 220 | DMAC | DiaMedica Therapeutics Inc. | 474.29M | -5.79% | 214,090 | - |
| 221 | STTK | Shattuck Labs, Inc. | 473.57M | -3.33% | 775,896 | 1.00M |
| 222 | GYRE | Gyre Therapeutics, Inc. | 471.74M | 0.23% | 281,341 | 110.06M |
| 223 | OCS | Oculis Holding AG | 471.63M | 1.87% | 183,973 | 1.12M |
| 224 | MDXG | MiMedx Group, Inc. | 468.42M | -0.93% | 1,127,509 | 303.73M |
| 225 | RLMD | Relmada Therapeutics, Inc. | 449.19M | 1.20% | 1,736,265 | - |
| 226 | AVTX | Avalo Therapeutics, Inc. | 448.71M | 0.78% | 974,224 | 59.00K |
| 227 | ARVN | Arvinas, Inc. | 446.61M | -0.73% | 879,352 | 275.30M |
| 228 | BLSM | BlossomHill Therapeutics, Inc. | 445.62M | -5.53% | 222,586 | - |
| 229 | CTMX | CytomX Therapeutics, Inc. | 444.73M | 0.00% | 2,724,695 | 14.03M |
| 230 | ASMB | Assembly Biosciences, Inc. | 432.48M | 4.66% | 318,848 | 67.01M |
| 231 | PRTA | Prothena Corporation plc | 419.01M | -0.85% | 340,447 | 52.74M |
| 232 | SLBT | SL Science Holding Limited | 414.58M | -4.88% | 25,230 | 3.27M |
| 233 | TECX | Tectonic Therapeutic, Inc. | 413.27M | 0.48% | 300,637 | - |
| 234 | FENC | Fennec Pharmaceuticals Inc. | 410.25M | 6.61% | 461,083 | 66.37M |
| 235 | MPLT | MapLight Therapeutics, Inc. | 402.92M | 2.55% | 367,746 | - |
| 236 | PBYI | Puma Biotechnology, Inc. | 401.70M | -3.84% | 403,673 | 231.83M |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 391.06M | 2.10% | 1,297,296 | 122.14M |
| 238 | CTNM | Contineum Therapeutics, Inc. | 387.16M | 0.82% | 265,893 | - |
| 239 | IRD | Opus Genetics, Inc. | 384.68M | -1.97% | 747,200 | 7.91M |
| 240 | RZLT | Rezolute, Inc. | 383.42M | -5.56% | 5,736,194 | - |
| 241 | ALEC | Alector, Inc. | 378.15M | 3.67% | 1,799,091 | 173.47M |
| 242 | CRMD | CorMedix Inc. | 370.65M | -3.72% | 2,391,240 | 412.49M |
| 243 | TRXB | TRex Bio, Inc. | 368.02M | -3.05% | 62,667 | - |
| 244 | ASPE | Aspen Neuroscience, Inc. | 366.10M | -7.49% | 173,574 | - |
| 245 | CCCC | C4 Therapeutics, Inc. | 362.44M | -0.36% | 2,543,574 | 32.28M |
| 246 | PRLD | Prelude Therapeutics Incorporated | 355.33M | -1.99% | 262,091 | 22.42M |
| 247 | LYEL | Lyell Immunopharma, Inc. | 351.57M | -8.57% | 236,615 | 15.00K |
| 248 | YDES | YD Bio Limited | 345.66M | -6.06% | 25,888 | 1.24M |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 345.31M | 2.14% | 302,651 | - |
| 250 | EDIT | Editas Medicine, Inc. | 334.92M | 1.40% | 2,791,697 | 49.83M |
| 251 | EIKN | Eikon Therapeutics, Inc. | 324.03M | -0.99% | 292,791 | - |
| 252 | ALT | Altimmune, Inc. | 320.10M | 2.17% | 3,533,796 | 26.00K |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 320.09M | -1.87% | 127,692 | 65.26M |
| 254 | KYTX | Kyverna Therapeutics, Inc. | 319.27M | 0.40% | 673,356 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 318.59M | -1.58% | 501,341 | 16.96M |
| 256 | PROK | ProKidney Corp. | 315.99M | -9.13% | 1,291,649 | 775.00K |
| 257 | EVMN | Evommune, Inc. | 315.50M | -4.86% | 693,995 | 10.00M |
| 258 | BNTC | Benitec Biopharma Inc. | 315.34M | -0.55% | 144,689 | - |
| 259 | LRMR | Larimar Therapeutics, Inc. | 315.24M | 11.85% | 2,531,400 | - |
| 260 | AGMB | AgomAb Therapeutics NV | 313.22M | 0.00% | 192,627 | - |
| 261 | AUTL | Autolus Therapeutics plc | 311.41M | -1.68% | 1,795,519 | 137.43M |
| 262 | SCTX | Scribe Therapeutics Inc. | 309.82M | -3.71% | 330,570 | 14.83M |
| 263 | GALT | Galectin Therapeutics Inc. | 307.59M | -2.87% | 181,586 | - |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 305.27M | -0.65% | 333,110 | 1.00 |
| 265 | AGEN | Agenus Inc. | 304.51M | -2.04% | 465,149 | 133.95M |
| 266 | PEPG | PepGen Inc. | 301.97M | -13.49% | 5,699,217 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 299.64M | 1.23% | 373,172 | 109.16M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 295.50M | -2.52% | 1,882,097 | 424.00K |
| 269 | ALLO | Allogene Therapeutics, Inc. | 290.58M | 1.41% | 11,220,437 | 4.64M |
| 270 | DTIL | Precision BioSciences, Inc. | 288.76M | -5.91% | 394,619 | 45.04M |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 287.96M | 2.45% | 1,364,497 | 80.00M |
| 272 | VCRE | Vicore Pharma Holding AB (publ) | 282.67M | -5.73% | 17,889 | 383.48K |
| 273 | OCGN | Ocugen, Inc. | 280.88M | -5.24% | 16,661,517 | 4.78M |
| 274 | TTRX | Turn Therapeutics Inc. | 278.37M | -7.75% | 92,173 | - |
| 275 | CABA | Cabaletta Bio, Inc. | 276.12M | -3.76% | 3,225,197 | - |
| 276 | SABS | SAB Biotherapeutics, Inc. | 266.66M | -3.90% | 658,118 | 114.70K |
| 277 | QTTB | Q32 Bio Inc. | 260.64M | -1.25% | 243,792 | 53.74M |
| 278 | FTH | Faeth Therapeutics, Inc. | 259.18M | -5.82% | 974,168 | - |
| 279 | PLX | Protalix BioTherapeutics, Inc. | 257.17M | 3.04% | 1,529,041 | 84.69M |
| 280 | INO | Inovio Pharmaceuticals, Inc. | 256.89M | -2.05% | 4,959,581 | 298.90K |
| 281 | RCKT | Rocket Pharmaceuticals, Inc. | 256.82M | -3.77% | 1,783,920 | - |
| 282 | CUVL | Clinuvel Pharmaceuticals Limited | 253.61M | 0.00% | 352 | 65.05M |
| 283 | VOGX | Vogenx, Inc. | 247.63M | -12.95% | 89,697 | - |
| 284 | VTVT | vTv Therapeutics Inc. | 245.01M | -4.83% | 17,398 | 36.84M |
| 285 | VNDA | Vanda Pharmaceuticals Inc. | 241.27M | 1.01% | 824,783 | 229.28M |
| 286 | ARCT | Arcturus Therapeutics Holdings Inc. | 240.96M | -0.95% | 377,086 | 30.51M |
| 287 | IMRX | Immuneering Corporation | 240.27M | 1.09% | 849,189 | - |
| 288 | CAMP | Camp4 Therapeutics Corporation | 238.47M | -7.09% | 46,161 | 5.32M |
| 289 | BCYC | Bicycle Therapeutics plc | 236.22M | -2.32% | 604,364 | 83.53M |
| 290 | LXEO | Lexeo Therapeutics, Inc. | 235.46M | -1.37% | 446,906 | - |
| 291 | LCTX | Lineage Cell Therapeutics, Inc. | 233.36M | -7.64% | 1,976,667 | 10.84M |
| 292 | DRUG | Bright Minds Biosciences Inc. | 226.67M | 1.63% | 118,565 | - |
| 293 | GLSI | Greenwich LifeSciences, Inc. | 219.29M | -2.23% | 69,410 | - |
| 294 | ACIU | AC Immune SA | 211.78M | -0.47% | 114,784 | 23.75M |
| 295 | NGEN | NervGen Pharma Corp. | 202.14M | 15.34% | 1,993,140 | - |
| 296 | KROS | Keros Therapeutics, Inc. | 202.13M | 2.18% | 167,040 | 40.76M |
| 297 | PALI | Palisade Bio, Inc. | 200.79M | -1.75% | 1,292,939 | 500.00K |
| 298 | PRQR | ProQR Therapeutics N.V. | 198.98M | 3.68% | 568,639 | 23.46M |
| 299 | CGEN | Compugen Ltd. | 198.92M | -0.94% | 209,584 | 75.93M |
| 300 | ARTV | Artiva Biotherapeutics, Inc. | 198.22M | 1.26% | 868,506 | 251.00K |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 193.69M | -0.08% | 106,818 | 1.03M |
| 302 | PYXS | Pyxis Oncology, Inc. | 188.98M | 0.00% | 359,904 | 11.04M |
| 303 | KRRO | Korro Bio, Inc. | 186.81M | -4.89% | 78,960 | 1.29M |
| 304 | TRDA | Entrada Therapeutics, Inc. | 185.82M | -1.55% | 791,634 | 3.98M |
| 305 | MDWD | MediWound Ltd. | 184.34M | -0.54% | 190,278 | 10.01M |
| 306 | ACOG | Alpha Cognition Inc. | 180.76M | -3.04% | 87,288 | 20.20M |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 180.57M | -0.33% | 212,182 | 7.15M |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 180.46M | -2.01% | 34,621 | 1.44M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 178.80M | -10.57% | 1,518,674 | - |
| 310 | ANTX | AN2 Therapeutics, Inc. | 172.64M | 2.48% | 205,666 | - |
| 311 | IFRX | InflaRx N.V. | 172.42M | -5.65% | 220,952 | -38.53K |
| 312 | IVVD | Invivyd, Inc. | 171.58M | 2.61% | 2,887,559 | 58.37M |
| 313 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 171.57M | -8.94% | 677,600 | - |
| 314 | YARW | Yarrow Bioscience, Inc. | 167.76M | -8.15% | 99,111 | - |
| 315 | ZNTL | Zentalis Pharmaceuticals, Inc. | 167.05M | 1.19% | 1,300,020 | 26.87M |
| 316 | STRO | Sutro Biopharma, Inc. | 163.03M | 2.40% | 333,445 | 45.11M |
| 317 | RNA | Atrium Therapeutics, Inc. | 162.00M | 0.13% | 195,172 | 38.82M |
| 318 | ENGN | enGene Therapeutics Inc. | 161.51M | 5.70% | 3,620,630 | - |
| 319 | ORMP | Oramed Pharmaceuticals Inc. | 161.33M | -7.94% | 161,313 | 2.00M |
| 320 | VRXA | Veraxa Biotech AG | 156.96M | -3.48% | 114,127 | 29.54K |
| 321 | TARA | Protara Therapeutics, Inc. | 155.77M | 3.69% | 728,215 | - |
| 322 | FATE | Fate Therapeutics, Inc. | 155.61M | -4.48% | 1,806,870 | 4.75M |
| 323 | HUMA | Humacyte, Inc. | 155.12M | -6.21% | 4,294,900 | 2.40M |
| 324 | UPB | Upstream Bio, Inc. | 152.38M | -2.80% | 891,334 | 2.87M |
| 325 | SION | Sionna Therapeutics, Inc. | 150.63M | -2.92% | 470,236 | - |
| 326 | ARMP | Armata Pharmaceuticals, Inc. | 143.94M | 4.03% | 23,374 | 7.56M |
| 327 | ALXO | ALX Oncology Holdings Inc. | 143.81M | -3.70% | 672,987 | - |
| 328 | MGNX | MacroGenics, Inc. | 140.60M | -3.93% | 997,828 | 140.81M |
| 329 | CMPX | Compass Therapeutics, Inc. | 139.35M | -5.63% | 1,550,026 | 850.00K |
| 330 | ABEO | Abeona Therapeutics Inc. | 138.30M | 5.68% | 3,176,469 | 39.01M |
| 331 | MSLE | Satellos Bioscience Inc. | 138.14M | -3.00% | 47,721 | - |
| 332 | NTHI | NeOnc Technologies Holdings, Inc. | 136.36M | 1.24% | 251,853 | 39.99K |
| 333 | CNTN | Canton Strategic Holdings, Inc. | 136.26M | -5.00% | 504,556 | 1.50M |
| 334 | MENS | Jyong Biotech Ltd. | 130.65M | 4.76% | 27,028 | - |
| 335 | LENZ | LENZ Therapeutics, Inc. | 129.77M | 0.98% | 748,570 | 12.36M |
| 336 | PYPD | PolyPid Ltd. | 127.15M | -2.19% | 193,085 | - |
| 337 | CDXS | Codexis, Inc. | 127.13M | 21.07% | 2,501,749 | 88.34M |
| 338 | SPRB | Spruce Biosciences, Inc. | 124.47M | 0.98% | 38,862 | 697.00K |
| 339 | FHTX | Foghorn Therapeutics Inc. | 124.12M | 0.98% | 534,206 | 112.13M |
| 340 | IPHA | Innate Pharma S.A. | 124.08M | -7.38% | 16,551 | 11.21M |
| 341 | ZURA | Zura Bio Limited | 119.44M | 0.00% | 4,245,891 | - |
| 342 | CUE | Cue Biopharma, Inc. | 117.10M | -7.89% | 274,901 | 37.66M |
| 343 | ADAG | Adagene Inc. | 114.82M | -14.50% | 152,058 | 9.29M |
| 344 | NERV | Minerva Neurosciences, Inc. | 114.62M | -3.36% | 74,567 | - |
| 345 | MOLN | Molecular Partners AG | 109.77M | -2.33% | 1,410 | 856.30K |
| 346 | VYGR | Voyager Therapeutics, Inc. | 107.66M | 1.76% | 806,627 | 25.11M |
| 347 | OKUR | OnKure Therapeutics, Inc. | 106.52M | -12.62% | 891,350 | - |
| 348 | IMUX | Immunic, Inc. | 102.61M | -3.47% | 105,527 | - |
| 349 | RTSN | Retension Pharmaceuticals, Inc. | 102.23M | 0.16% | 124,990 | - |
| 350 | EQ | Equillium, Inc. | 101.09M | -2.27% | 472,250 | 4.39M |
| 351 | OTLK | Outlook Therapeutics, Inc. | 100.54M | -6.16% | 3,025,431 | -1.16M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 98.89M | -2.47% | 690,181 | - |
| 353 | NBP | NovaBridge Biosciences | 98.59M | 2.40% | 778,441 | - |
| 354 | ICCC | ImmuCell Corporation | 97.63M | 5.19% | 40,752 | 33.21M |
| 355 | PMVP | PMV Pharmaceuticals, Inc. | 95.90M | 4.96% | 290,751 | - |
| 356 | NRXP | NRx Pharmaceuticals, Inc. | 94.75M | -3.95% | 1,030,220 | 3.39M |
| 357 | TVGN | Tevogen Inc. | 94.42M | 4.90% | 3,807 | - |
| 358 | VANI | Vivani Medical, Inc. | 91.11M | 2.70% | 359,333 | - |
| 359 | ANIX | Anixa Biosciences, Inc. | 91.08M | -2.24% | 278,609 | - |
| 360 | KZIA | Kazia Therapeutics Limited | 90.72M | -4.75% | 352,750 | 1.27M |
| 361 | HURA | TuHURA Biosciences, Inc. | 88.58M | -4.14% | 371,823 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 88.23M | -5.85% | 9,883 | - |
| 363 | SEER | Seer, Inc. | 86.93M | -1.26% | 122,459 | 14.08M |
| 364 | TENX | Tenax Therapeutics, Inc. | 86.85M | 0.62% | 901,931 | - |
| 365 | AVXL | Anavex Life Sciences Corp. | 86.53M | -5.65% | 1,199,960 | - |
| 366 | CBUS | Cibus, Inc. | 86.36M | 3.67% | 141,434 | 4.53M |
| 367 | NKTX | Nkarta, Inc. | 85.33M | -5.93% | 1,406,989 | - |
| 368 | RLYB | Rallybio Corporation | 84.64M | 0.45% | 10,528 | 434.00K |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 84.48M | -3.29% | 902,839 | 70.00M |
| 370 | GNLX | Genelux Corporation | 83.57M | -1.84% | 179,401 | 8.00K |
| 371 | CHRS | Coherus Oncology, Inc. | 81.21M | -2.41% | 4,306,205 | 53.64M |
| 372 | NMRA | Neumora Therapeutics, Inc. | 80.59M | -0.95% | 497,567 | - |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 79.59M | 0.49% | 1,281,344 | 3.03M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 77.29M | -2.90% | 17,032 | 3.97M |
| 375 | CLLS | Cellectis S.A. | 75.16M | -11.28% | 72,011 | 63.82M |
| 376 | NTRB | Nutriband Inc. | 74.15M | 2.18% | 28,925 | 1.62M |
| 377 | COYA | Coya Therapeutics, Inc. | 73.42M | -4.28% | 189,167 | 4.69M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 73.36M | 0.21% | 552,868 | 6.58M |
| 379 | MIST | Milestone Pharmaceuticals Inc. | 73.27M | -20.63% | 3,885,874 | 2.34M |
| 380 | TLSA | Tiziana Life Sciences Ltd | 72.96M | -6.65% | 266,696 | - |
| 381 | OKYO | OKYO Pharma Limited | 70.85M | -3.57% | 264,095 | - |
| 382 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 69.86M | -0.59% | 575,119 | - |
| 383 | MNOV | MediciNova, Inc. | 68.66M | -0.36% | 61,647 | 920.48K |
| 384 | NRXS | NeurAxis, Inc. | 68.06M | -5.74% | 182,862 | 6.53M |
| 385 | CNXU | Conexeu Sciences Inc. | 67.21M | 0.00% | 192,992 | - |
| 386 | GOSS | Gossamer Bio, Inc. | 67.10M | -2.40% | 124,138 | 78.42M |
| 387 | CSBR | Champions Oncology, Inc. | 65.49M | 1.18% | 3,020 | 60.66M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 64.65M | 0.52% | 277,587 | - |
| 389 | PDSB | PDS Biotechnology Corporation | 63.24M | -10.96% | 5,830,705 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 62.70M | -5.53% | 310,598 | 68.47M |
| 391 | CING | Cingulate Inc. | 62.53M | -4.23% | 188,350 | - |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 62.14M | -0.68% | 199,706 | - |
| 393 | VRCA | Verrica Pharmaceuticals Inc. | 61.16M | -4.30% | 18,663 | 22.89M |
| 394 | MAIA | MAIA Biotechnology, Inc. | 60.83M | -0.99% | 362,675 | - |
| 395 | XBIT | XBiotech Inc. | 59.76M | 0.00% | 105,424 | - |
| 396 | HRTX | Heron Therapeutics, Inc. | 59.08M | -4.73% | 2,481,620 | 148.22M |
| 397 | TNXP | Tonix Pharmaceuticals Holding Corp. | 58.49M | -7.10% | 1,932,980 | 43.05M |
| 398 | AZR | Azora Therapeutics, Inc. | 58.25M | 9.36% | 10,965 | - |
| 399 | SPRO | Spero Therapeutics, Inc. | 58.23M | -0.01% | 357,473 | 47.00M |
| 400 | ANVS | Annovis Bio, Inc. | 57.44M | 9.31% | 2,197,306 | - |
| 401 | BOLD | Boundless Bio, Inc. | 56.87M | 1.63% | 156,469 | - |
| 402 | CRDF | Cardiff Oncology, Inc. | 56.49M | -0.21% | 203,701 | 559.00K |
| 403 | CLNN | Clene Inc. | 56.45M | -2.00% | 28,739 | 238.00K |
| 404 | XLO | Xilio Therapeutics, Inc. | 53.13M | -2.00% | 7,581 | 55.01M |
| 405 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.08M | 2.02% | 14,757 | - |
| 406 | ATNM | Actinium Pharmaceuticals, Inc. | 51.56M | 3.14% | 178,824 | 35.09M |
| 407 | RNXT | RenovoRx, Inc. | 50.18M | -10.34% | 815,136 | 2.78M |
| 408 | MREO | Mereo BioPharma Group plc | 49.10M | 0.82% | 895,272 | 800.00K |
| 409 | NORD | Nordicus Partners Corporation | 48.95M | -7.04% | 10,038 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 47.66M | -1.99% | 18,950 | 200.00K |
| 411 | HOWL | Werewolf Therapeutics, Inc. | 47.64M | 0.03% | 317,764 | 21.00M |
| 412 | RNTX | Rein Therapeutics Inc. | 47.63M | -1.41% | 488,671 | - |
| 413 | ONCY | Oncolytics Biotech Inc. | 47.18M | -0.54% | 1,263,696 | - |
| 414 | IBIO | iBio, Inc. | 47.05M | -4.00% | 463,715 | 1.08M |
| 415 | HYFT | MindWalk Holdings Corp. | 46.64M | -1.00% | 350,322 | 11.57M |
| 416 | GANX | Gain Therapeutics, Inc. | 45.39M | -3.70% | 328,877 | - |
| 417 | IBO | Impact BioMedical Inc. | 43.91M | 7.76% | 7,991 | 38.00K |
| 418 | PLRX | Pliant Therapeutics, Inc. | 43.16M | -5.81% | 877,129 | - |
| 419 | CNTB | Connect Biopharma Holdings Limited | 42.65M | 1.79% | 236,003 | 2.95M |
| 420 | ELTX | Elicio Therapeutics, Inc. | 42.46M | -3.85% | 326,877 | - |
| 421 | DWTX | Dogwood Therapeutics, Inc. | 42.43M | -0.89% | 74,648 | 100.00K |
| 422 | BMEA | Biomea Fusion, Inc. | 42.20M | 3.47% | 555,570 | - |
| 423 | TIL | Instil Bio, Inc. | 41.23M | -2.56% | 51,629 | - |
| 424 | IRLA | IRulya Therapeutics Inc. | 40.48M | 0.05% | 55,385 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 40.09M | -5.15% | 200,494 | 1.91M |
| 426 | IMA | ImageneBio, Inc. | 39.39M | 0.58% | 4,024 | 800.00K |
| 427 | ALPS | Alps Group Inc | 39.27M | 0.43% | 28,894 | 3.74M |
| 428 | CRBU | Caribou Biosciences, Inc. | 39.10M | -4.81% | 1,505,394 | 9.44M |
| 429 | ALDX | Aldeyra Therapeutics, Inc. | 38.84M | 2.17% | 764,019 | - |
| 430 | APLM | Apollomics, Inc. | 38.83M | 2.20% | 8,403 | 413.00K |
| 431 | ATHE | Alterity Therapeutics Limited | 38.82M | -6.44% | 109,692 | 2.50M |
| 432 | GRCE | Grace Therapeutics, Inc. | 38.08M | 0.00% | 13,556 | - |
| 433 | KLRS | Kalaris Therapeutics, Inc. | 37.49M | -5.12% | 40,952 | - |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 36.12M | -1.96% | 129,469 | - |
| 435 | VERU | Veru Inc. | 35.64M | -1.42% | 90,522 | 16.89M |
| 436 | EXOZ | eXoZymes, Inc. | 35.55M | -4.25% | 20,052 | -700.00 |
| 437 | SER | Serina Therapeutics, Inc. | 35.31M | -1.42% | 10,549 | 125.00K |
| 438 | EYPT | EyePoint, Inc. | 34.82M | -4.23% | 3,086,415 | 2.58M |
| 439 | OSTX | OS Therapies Incorporated | 34.42M | -0.68% | 805,023 | - |
| 440 | LONA | LeonaBio, Inc. | 32.69M | -6.97% | 14,077 | - |
| 441 | INMB | INmune Bio Inc. | 32.51M | 0.00% | 476,498 | 50.00K |
| 442 | NNVC | NanoViricides, Inc. | 31.40M | -8.89% | 167,890 | - |
| 443 | ACET | Adicet Bio, Inc. | 29.92M | -5.12% | 286,376 | - |
| 444 | PMN | ProMIS Neurosciences, Inc. | 29.50M | -5.46% | 156,539 | - |
| 445 | NXTC | NextCure, Inc. | 29.30M | 2.73% | 37,676 | - |
| 446 | AARD | Aardvark Therapeutics, Inc. | 29.11M | -12.50% | 403,064 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 28.99M | -3.42% | 25,188 | - |
| 448 | PTHS | Pelthos Therapeutics Inc. | 28.48M | -7.35% | 51,404 | 43.30M |
| 449 | PLRZ | Polyrizon Ltd. | 26.84M | -3.75% | 5,743 | - |
| 450 | GRDX | GridAI Technologies Corp. | 26.48M | -31.00% | 503,847 | - |
| 451 | EDSA | Edesa Biotech, Inc. | 26.21M | -6.73% | 510,717 | - |
| 452 | MGX | Metagenomi Therapeutics, Inc. | 26.13M | -3.12% | 119,228 | 7.09M |
| 453 | LITS | Lite Strategy, Inc. | 25.75M | -6.64% | 435,399 | - |
| 454 | CRVO | CervoMed Inc. | 25.57M | -7.65% | 640,375 | 8.73K |
| 455 | EVAX | Evaxion A/S | 25.27M | -1.08% | 48,579 | 7.49M |
| 456 | BYSI | BeyondSpring Inc. | 24.72M | 0.03% | 31,884 | 1.88M |
| 457 | IMMP | Immutep Limited | 23.89M | -4.79% | 14,849 | 13.79M |
| 458 | ABVC | ABVC BioPharma, Inc. | 23.63M | -5.56% | 38,115 | 797.92K |
| 459 | CVM | CEL-SCI Corporation | 22.51M | 7.56% | 145,431 | - |
| 460 | ESLA | Estrella Immunopharma, Inc. | 22.36M | -0.94% | 222,768 | - |
| 461 | RNAZ | TransCode Therapeutics, Inc. | 22.35M | -5.06% | 20,839 | - |
| 462 | FLNA | Filana Therapeutics, Inc. | 21.37M | -5.11% | 320,074 | - |
| 463 | CELU | Celularity Inc. | 20.45M | -7.99% | 138,757 | 18.67M |
| 464 | ATOS | Atossa Therapeutics, Inc. | 19.56M | 1.03% | 56,354 | - |
| 465 | BSEM | BioStem Technologies, Inc. | 19.51M | -19.23% | 450,132 | 34.59M |
| 466 | LPCN | Lipocine Inc. | 18.94M | 5.56% | 215,056 | 3.74M |
| 467 | COCP | Cocrystal Pharma, Inc. | 18.88M | -1.00% | 12,132 | 330.00K |
| 468 | IGC | IGC Pharma, Inc. | 18.20M | -4.61% | 498,145 | 1.11M |
| 469 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.78M | -1.33% | 16,030 | - |
| 470 | KTTA | Pasithea Therapeutics Corp. | 17.44M | 0.40% | 2,344,054 | - |
| 471 | CNTX | Context Therapeutics Inc. | 16.61M | -8.69% | 938,959 | - |
| 472 | TVRD | Tvardi Therapeutics, Inc. | 15.74M | 2.16% | 75,658 | - |
| 473 | ACTU | Actuate Therapeutics, Inc. | 15.69M | -3.61% | 174,061 | - |
| 474 | AKTX | Akari Therapeutics, Plc | 15.54M | 4.45% | 21,427 | - |
| 475 | ABOS | Acumen Pharmaceuticals, Inc. | 15.48M | -1.83% | 2,783,800 | - |
| 476 | BIVI | BioVie Inc. | 15.22M | -5.04% | 217,948 | - |
| 477 | ALLR | Allarity Therapeutics, Inc. | 15.18M | 4.38% | 279,278 | 345.00K |
| 478 | JSPR | Jasper Therapeutics, Inc. | 15.17M | 2.32% | 16,494 | - |
| 479 | NCEL | NewcelX Ltd. | 15.08M | -2.97% | 12,041 | - |
| 480 | ATYR | aTyr Pharma, Inc. | 14.97M | -1.69% | 38,122 | 190.00K |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 14.69M | 0.51% | 173,129 | 7.11M |
| 482 | MRKR | Marker Therapeutics, Inc. | 14.51M | -3.33% | 72,385 | 3.55M |
| 483 | MCRB | Seres Therapeutics, Inc. | 14.27M | -0.71% | 59,944 | 2.13M |
| 484 | QNTM | Quantum BioPharma Ltd. | 14.11M | -9.55% | 80,377 | - |
| 485 | KYNB | Kyntra Bio, Inc. | 13.93M | -4.18% | 13,826 | 4.62M |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 13.80M | -1.16% | 14,966 | 1.17M |
| 487 | PASG | Passage Bio, Inc. | 13.68M | 5.99% | 11,930 | - |
| 488 | ALGS | Aligos Therapeutics, Inc. | 13.11M | 6.06% | 57,425 | 33.65M |
| 489 | PLUR | Pluri Inc. | 12.96M | -3.67% | 14,759 | 1.46M |
| 490 | DARE | Daré Bioscience, Inc. | 12.93M | 2.05% | 73,997 | 1.37M |
| 491 | BCDA | BioCardia, Inc. | 12.58M | 0.61% | 79,976 | 3.00K |
| 492 | PBM | Psyence Biomedical Ltd. | 12.00M | 1.78% | 43,251 | - |
| 493 | GUTS | Fractyl Health, Inc. | 11.99M | 11.27% | 420,331 | 3.00K |
| 494 | BOLT | Bolt Biotherapeutics, Inc. | 11.95M | 2.88% | 28,106 | 4.70M |
| 495 | DYAI | Dyadic International, Inc. | 11.92M | -6.60% | 189,367 | 3.80M |
| 496 | RADX | Radiopharm Theranostics Limited | 11.76M | -3.80% | 22,131 | 8.90M |
| 497 | HIND | Vyome Holdings, Inc. | 11.09M | -3.07% | 2,996 | 153.10K |
| 498 | CMMB | Chemomab Therapeutics Ltd. | 11.09M | 9.29% | 85,493 | - |
| 499 | LSTA | Lisata Therapeutics, Inc. | 10.90M | -5.47% | 104,781 | 100.00K |
| 500 | TCRX | TScan Therapeutics, Inc. | 10.89M | -4.40% | 227,682 | 5.19M |